Evaluation of the efficacy of sarolaner (Simparica®) in the prevention of babesiosis in dogs

Evaluation of the efficacy of sarolaner (Simparica®) in the prevention of babesiosis in dogs

Abstract Background Canine babesiosis is a clinically significant emerging vector-borne disease caused among others by the protozoan Babesia canis. The efficacy of sarolaner (Simparica®; Zoetis; at the minimum recommended label dose of 2.0 mg per kg bodyweight) in the prevention of babesiosis was ev...

Full description

Bibliographic Details
Main Authors: Thomas Geurden, Robert Six, Csilla Becskei, Steven Maeder, Anne Lloyd, Sean Mahabir, Josephus Fourie, Julian Liebenberg
Format: Article
Language:English
Published: BMC 2017-09-01
Series:Parasites & Vectors
Subjects:
Dogs
Dermacentor reticulatus
Babesia canis
Babesiosis
Transmission
Efficacy
Online Access:http://link.springer.com/article/10.1186/s13071-017-2358-3

Internet

http://link.springer.com/article/10.1186/s13071-017-2358-3

Similar Items